The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
Status:
Withdrawn
Trial end date:
2017-04-12
Target enrollment:
Participant gender:
Summary
Chlorthalidone might offer an effective, safe and inexpensive anti-hypertensive treatment for
kidney transplant patients who have resistant hypertension on multi-drug therapy. We will
collect initial data on the safety and efficacy of Chlorthalidone in the treatment of
patients with resistant hypertension.
To Examine the efficacy of chlorthalidone as an anti-hypertensive agent in the treatment of
resistant hypertension among stable kidney transplant recipients